2results about How to "Increase breathing intensity" patented technology

An intelligent respiratory training instrument disclosed by the present invention comprises an integrated box, a breathing mask, an electrical stimulation patch and a box body, the inner wall of the breathing mask is fixedly connected with an oral cavity tube in a penetrating manner, the side wall of the box body is fixedly connected with an adjusting tube in a penetrating manner, the inner wall of the adjusting tube is rotatably connected with a spline shaft in a penetrating manner, and the side wall of the spline shaft is fixedly provided with an impeller. An H-shaped plate is fixedly connected to the side wall of the top of the spline shaft, connecting rods are rotatably connected to the inner side walls of the two ends of the H-shaped plate, gravity balls are fixedly installed at the other ends of the connecting rods, a bottom plate is connected to the side wall of the spline shaft in a bonding mode, and pull rods are symmetrically and rotatably connected to the side wall of the bottom plate; the other end of each pull rod is rotationally connected with the adjacent connecting rod, and the bottom wall of the H-shaped plate is elastically connected with the bottom plate through a reset spring. By monitoring the intensity state of gas exhaled by a patient, the intensity state is fed back to the controller in the integrated box to automatically adjust training parameters, so that the optimal training effect is achieved.

This invention belongs to the field of agricultural biotechnology and discloses a low-temperature synergistic biological agent, its preparation method, and its application. The core innovation lies in using a unique engineered Bacillus subtilis strain as the core functional carrier, and performing a ternary targeted compounding with polydeoxyribonucleotides (PDRN) and biostimulants to achieve a triple synergistic low-temperature resistance effect. The engineered Bacillus subtilis strain was deposited at the China General Microbiological Culture Collection Center (CGMCC) on March 11, 2026, with accession number CGMCC No. 37899. The chassis strain of Bacillus subtilis was deposited at the same center on March 3, 2026, with accession number CGMCC No. 37834. The modification strategy involves knocking out the α-subunit gene of acetoin dehydrogenase and the phosphoacetyltransferase gene from the genome of Bacillus subtilis CGMCC No. 37834, and expressing the acetyllactate synthase gene and the α-acetyllactate decarboxylase gene.